{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-021397","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2022-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.218808+00:00","generated_at":"2026-06-26T05:06:03.585466+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"low","headline":"Lantern Pharma provides disclosure channels reminder; no material news","bullets":["Filing details company's website, press releases, SEC filings, newsletters, and social media as information channels.","No financial results, clinical updates, or material events reported.","Company reiterates emerging growth company status and extended transition period election."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-021397","json":"https://secwatch.observer/filing/0001213900-22-021397.json","markdown":"https://secwatch.observer/filing/0001213900-22-021397.md","text":"https://secwatch.observer/filing/0001213900-22-021397.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022021397/0001213900-22-021397-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022021397/ea158814-8k_lantern.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:06:03.585466+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}